Inventor · disambiguated record
Lior Carmon
Also filed as: CARMON LIOR · CARMON LIOR BINYAMIN
10 granted patents·7 pending applications·41 citations·filing 1999–2021
85Inventor score
Files withCARMON LIOR7VAXIL BIOTHERAPEUTICS LTD4YEDA RES & DEV3AMARIN CORP PLC1CARMON LIOR BINYAMIN1
Top patents by PatentIndex Score
17 records- 0184US7906620B2Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccinesYEDA RES & DEV·Filed 2003·Granted Mar 15, 2011·19 cites·15 claims
- 0283US7531629B2Tumor associated antigen peptides and use of same as anti-tumor vaccinesYEDA RES & DEV·Filed 2006·Granted May 12, 2009·3 cites·7 claims
- 0375US7084249B1Tumor associated antigen peptides and use of same as anti-tumor vaccinesYEDA RES & DEV·Filed 1999·Granted Aug 1, 2006·19 cites·4 claims
- 0474US11135277B2Antigen specific multi epitope-based anti-infective vaccinesCARMON LIOR·Filed 2019·Granted Oct 5, 2021·0 cites·20 claims
- 0573US2022111030A1Antigen specific multi epitope-based anti-infective vaccinesCARMON LIOR·Filed 2021·Application pending·0 cites
- 0666US10350284B1Antigen specific multi epitope-based anti-infective vaccinesCARMON LIOR·Filed 2019·Granted Jul 16, 2019·0 cites·20 claims
- 0763US9487574B2Antigen specific multi epitope vaccinesCARMON LIOR·Filed 2007·Granted Nov 8, 2016·0 cites·13 claims
- 0862US2022072113A1Antigen specific multi epitope vaccinesVAXIL BIOTHERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0960US10245309B2Antigen specific multi epitope-based anti-infective vaccinesCARMON LIOR·Filed 2017·Granted Apr 2, 2019·0 cites·20 claims
- 1058US2025101128A1Chimeric polypeptide compositions and encoding polynucleotides thereofCARMON LIOR BINYAMIN·Filed 2021·Application pending·0 cites
- 1156US11179452B2Antigen specific multi epitope vaccinesVAXIL BIOTHERAPEUTICS LTD·Filed 2016·Granted Nov 23, 2021·0 cites·13 claims
- 1254US2020062842A1Antibodies directed against signal peptides, methods and uses thereofVAXIL BIOTHERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1353US9642903B2Antigen specific multi epitope-based anti-infective vaccinesCARMON LIOR·Filed 2010·Granted May 9, 2017·0 cites·12 claims
- 1451US9732153B2Antibodies directed against signal peptides, methods and uses thereofCARMON LIOR·Filed 2012·Granted Aug 15, 2017·0 cites·3 claims
- 1546US2019185558A1Antibodies directed against signal peptides, methods and uses thereofVAXIL BIOTHERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 1646US2009275634A1Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseasesAMARIN CORP PLC·Filed 2007·Application pending·0 cites
- 1739US2012196920A1Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseasesHAZUM ELI·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lior Carmon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →